Endometrial Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged between 18 and 60 years old.
- People with cervical cancer where both radiation therapy and chemotherapy are considered appropriate treatments.
- People whose cervical cancer has been confirmed by pathology to be squamous cell carcinoma, adenocarcinoma, or adenosquamous carcinoma.
- People with a performance status score of 1 or lower on the ECOG scale, meaning they are generally able to carry out daily activities with little or no restriction (confirm with trial site).
- People with an expected survival of more than 3 months.
- Women who are pre-menopausal, or women who have been post-menopausal for at least 12 months, and who have a negative pregnancy test result.
- People who agree to use effective contraception throughout the study and for 6 months after treatment ends.
- People who are willing to participate voluntarily, sign a consent form, and are able to attend all study visits and follow-up appointments.
Who may not be able to join:
- People who have been clinically diagnosed with a bone marrow disease.
- People where imaging or pathology has identified cancer that has spread to the central nervous system, the lining of the brain, bones, or bone marrow.
- People with severe heart failure.
- People who have previously had an allogeneic stem cell transplant or an organ transplant.
- People with active bleeding or a condition called autoimmune thrombocytopenic purpura (a disorder affecting blood platelets).
- People for whom radiation therapy or chemotherapy is medically unsuitable or contraindicated.
- People who test positive for HIV.
- People with an active hepatitis B or hepatitis C infection (either acute or chronic).
- People with a history of certain serious digestive system conditions within the past 6 months, including bowel perforation or fistula, bowel obstruction, inflammatory bowel disease, extensive bowel surgery, Crohn's disease, ulcerative colitis, or chronic diarrhoea.
- People with evidence of unexplained air in the abdominal cavity that cannot be accounted for by a recent medical procedure or surgery.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Dongling Zou, M.D., Chongqing University Cancer Hospital
Phone: 13657690699
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Incidence of Grade 3-4 neutropenia; Time to reconstruct haematopoietic function
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.